1|Page
CCRP AACVPR EXAM NEWEST 2025 ACTUAL EXAM 300
QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) |ALREADY GRADED A+||NEWEST VERSION, EXAMS OF
NUTRITION
ACC/AHA Lifestyle Management Guidelines Dietary recommendations for lowering LDL-C -
ANSWER-1) consume a dietary pattern that emphasizes; vegetables, whole grains and fruits; low
fat dairy products, fish, legumes, non-tropical oils and nuts; limit sweets, sugared beverages and
red meats
2) Aim for a diet of 5-6% of calories from saturated fats
3) Reduce percent calories from saturated fats
4) Reduce percent of calories from trans fats
What are unrefined carbohydrates referred as - ANSWER-whole grains
Strongest evidence for dietary patterns - ANSWER-DASH diet
(dietary approach to stop hypertension)
Function of statins - ANSWER-reduce cholesterol production in the liver by inhibiting the
enzyme HMG CoA reductase
When to investigate into possible secondary causes of hyperlipidemia - ANSWER-LDL-C >190
mg/dL and triglycerides >600mg/dL
LDL-C reduction on low intensity statin - ANSWER-<30%
LDL-C reduction on moderate intensity statin - ANSWER-30-<50%
,2|Page
LDL-C reduction on high intensity statin - ANSWER->50%
Secondary causes of elevated LDL - ANSWER-diets high in saturated fat/trans fat, weight gain,
anorexia, diuretics, cyclosporine, glucocorticoids, amiodarone, binary obstruction, nephrotic
syndrome, hypothyroidism, obesity, pregnancy
Secondary causes of elevated triglycerides - ANSWER-Diets high in refined carbs, weight gain,
very low fat diets, excessive alcohol intake, estrogens, glucocorticoids, bile acid sequestrates,
protease inhibitors, retinoid acid, anabolic steroids, sirolimus, ralozifene, tamoxifen, beta
blockers, thiazide diuretics, chronic renal failure, nephrotic syndrome, lipodystrophies, diabetes,
hypothyroidism, obesity, pregnancy
Rosuvastatin 5, 10mg intensity - ANSWER-moderate
Rosuvastatin 20, 40 mg intensity - ANSWER-high
Atorvastatin 10, 20 mg intensity - ANSWER-moderate
Atorvastatin 40, 80mg intensity - ANSWER-high
Simvastatin 10mg intensity - ANSWER-low
Simvastatin 20, 40 mg intensity - ANSWER-moderate
Pravastatin 10, 20 mg intensity - ANSWER-low
Pravastatin 40, 80mg intensity - ANSWER-moderate
,3|Page
Lovastatin 20mg intensity - ANSWER-low
Lovastatin 40mg intensity - ANSWER-moderate
Fluvastatin XL 80mg intensity - ANSWER-moderate
Fluvastatin 20, 40mg intensity - ANSWER-low
Fluvastatin 40 mg BID intensity - ANSWER-moderate
Pitavastatin 1mg intensity - ANSWER-low
Pitavastatin 2, 4mg intensity - ANSWER-moderate
Moderate - High intensity Statins - ANSWER-Rosuvastatin, Atorvastatin
Low-Moderate intensity Statin - ANSWER-Simvastatin
Pravastatin
Lovastatin
Fluvastatin
Pitavastatin
What is the decision based on about whether to initiate statin therapy and what dose -
ANSWER-based on an individuals global CVD risk rather than LDL level
, 4|Page
Reassessment recommendations of lipid profile repeating - ANSWER-repeat in 4-12 weeks after
initiation of statin therapy and 3-12 months periodically thereafter to access for the expected
response to therapy
Four clinical groups that benefit from statin therapy - ANSWER--Clinical ASCVD
-LDL-C ≥190
-Diabetes, aged 40-75, LDL 70-189 and no clinical ASCVD
-Aged 45-70, LDL 70-189, no diabetes or clinical ASCVD and 10 year risk for ASCVD ≥7.5%
Intensity of statin recommended for groups with Clinical ASCVD - ANSWER-High intensity for
those ≤75
Moderate intensity for those >75
Intensity of statin recommended for groups with LDL ≥190 - ANSWER-High intensity
Intensity of statin recommended for groups with Diabetes, aged 40-75, LDL 70-189 and no
clinical ASCVD - ANSWER-Moderate intensity
*If 10 year risk ≥7.5%, option use of high intensity
Intensity of statin recommended for groups with Ages 45-70, LDL 70-189, no DM, or clinical
ASCVD and 10 year risk for ASCVD ≥7.5% - ANSWER-Moderate to high intensity
Clinical ASCVD - ANSWER-- acute coronary syndrome
- history of MI
- stable or unstable angina
- coronary or other arterial revascularization
- stroke/TIA
CCRP AACVPR EXAM NEWEST 2025 ACTUAL EXAM 300
QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) |ALREADY GRADED A+||NEWEST VERSION, EXAMS OF
NUTRITION
ACC/AHA Lifestyle Management Guidelines Dietary recommendations for lowering LDL-C -
ANSWER-1) consume a dietary pattern that emphasizes; vegetables, whole grains and fruits; low
fat dairy products, fish, legumes, non-tropical oils and nuts; limit sweets, sugared beverages and
red meats
2) Aim for a diet of 5-6% of calories from saturated fats
3) Reduce percent calories from saturated fats
4) Reduce percent of calories from trans fats
What are unrefined carbohydrates referred as - ANSWER-whole grains
Strongest evidence for dietary patterns - ANSWER-DASH diet
(dietary approach to stop hypertension)
Function of statins - ANSWER-reduce cholesterol production in the liver by inhibiting the
enzyme HMG CoA reductase
When to investigate into possible secondary causes of hyperlipidemia - ANSWER-LDL-C >190
mg/dL and triglycerides >600mg/dL
LDL-C reduction on low intensity statin - ANSWER-<30%
LDL-C reduction on moderate intensity statin - ANSWER-30-<50%
,2|Page
LDL-C reduction on high intensity statin - ANSWER->50%
Secondary causes of elevated LDL - ANSWER-diets high in saturated fat/trans fat, weight gain,
anorexia, diuretics, cyclosporine, glucocorticoids, amiodarone, binary obstruction, nephrotic
syndrome, hypothyroidism, obesity, pregnancy
Secondary causes of elevated triglycerides - ANSWER-Diets high in refined carbs, weight gain,
very low fat diets, excessive alcohol intake, estrogens, glucocorticoids, bile acid sequestrates,
protease inhibitors, retinoid acid, anabolic steroids, sirolimus, ralozifene, tamoxifen, beta
blockers, thiazide diuretics, chronic renal failure, nephrotic syndrome, lipodystrophies, diabetes,
hypothyroidism, obesity, pregnancy
Rosuvastatin 5, 10mg intensity - ANSWER-moderate
Rosuvastatin 20, 40 mg intensity - ANSWER-high
Atorvastatin 10, 20 mg intensity - ANSWER-moderate
Atorvastatin 40, 80mg intensity - ANSWER-high
Simvastatin 10mg intensity - ANSWER-low
Simvastatin 20, 40 mg intensity - ANSWER-moderate
Pravastatin 10, 20 mg intensity - ANSWER-low
Pravastatin 40, 80mg intensity - ANSWER-moderate
,3|Page
Lovastatin 20mg intensity - ANSWER-low
Lovastatin 40mg intensity - ANSWER-moderate
Fluvastatin XL 80mg intensity - ANSWER-moderate
Fluvastatin 20, 40mg intensity - ANSWER-low
Fluvastatin 40 mg BID intensity - ANSWER-moderate
Pitavastatin 1mg intensity - ANSWER-low
Pitavastatin 2, 4mg intensity - ANSWER-moderate
Moderate - High intensity Statins - ANSWER-Rosuvastatin, Atorvastatin
Low-Moderate intensity Statin - ANSWER-Simvastatin
Pravastatin
Lovastatin
Fluvastatin
Pitavastatin
What is the decision based on about whether to initiate statin therapy and what dose -
ANSWER-based on an individuals global CVD risk rather than LDL level
, 4|Page
Reassessment recommendations of lipid profile repeating - ANSWER-repeat in 4-12 weeks after
initiation of statin therapy and 3-12 months periodically thereafter to access for the expected
response to therapy
Four clinical groups that benefit from statin therapy - ANSWER--Clinical ASCVD
-LDL-C ≥190
-Diabetes, aged 40-75, LDL 70-189 and no clinical ASCVD
-Aged 45-70, LDL 70-189, no diabetes or clinical ASCVD and 10 year risk for ASCVD ≥7.5%
Intensity of statin recommended for groups with Clinical ASCVD - ANSWER-High intensity for
those ≤75
Moderate intensity for those >75
Intensity of statin recommended for groups with LDL ≥190 - ANSWER-High intensity
Intensity of statin recommended for groups with Diabetes, aged 40-75, LDL 70-189 and no
clinical ASCVD - ANSWER-Moderate intensity
*If 10 year risk ≥7.5%, option use of high intensity
Intensity of statin recommended for groups with Ages 45-70, LDL 70-189, no DM, or clinical
ASCVD and 10 year risk for ASCVD ≥7.5% - ANSWER-Moderate to high intensity
Clinical ASCVD - ANSWER-- acute coronary syndrome
- history of MI
- stable or unstable angina
- coronary or other arterial revascularization
- stroke/TIA
